Skip to main content
. 2015 Jun 5;14:236. doi: 10.1186/s12936-015-0744-x

Fig. 1.

Fig. 1

Details on study inclusion and follow up progress Bahir Dar district, March to July 2012. Among 778 malaria suspected and screened individuals, 134 P.f. mono-infected participants considered as eligible study subjects. Of them, 4 individuals excluded from the study and 130 study participants finished and drug efficacy and safety outcomes were drawn